Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.24) by 95.83 percent. This is a 17.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $84.05 million which beat the analyst consensus estimate of $83.55 million by 0.60 percent. This is a 19.80 percent increase over sales of $70.16 million the same period last year.